Avidity Biosciences Inc. (RNA)

RNA trades at $46.97, 14.6% above the near-term max pain of $41 expiring Oct 17, 2025 (12 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($7-$45), signaling increased put positioning or downside protection. Key magnetic zone at 20 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for RNA shows a downward trend from 45 to 7, indicating bearish sentiment or hedging activity. The 120% spread signals divergent expectations across timeframes. Most levels below 46.97 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.